
|Articles|December 24, 2012
Supplements and Featured Publications
- Improving Clinical and Managed Care Outcomes in Rheumatoid arthritis: a Focus on Comparative Effecti
- Volume 18
- Issue 13 Suppl
Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: A Focus on Comparative Effectiveness of Current Treatments
Advertisement
Instructions
After reading “Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: A Focus on Comparative Effectiveness of Current Treatments,” complete the program evaluation and select the single best answer to each of the posttest questions.
A statement of continuing education credit will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher on the posttest.
Articles in this issue
almost 14 years ago
Comparative Effectiveness of Current Treatments for Rheumatoid Arthritisalmost 14 years ago
Implications for Managed Care and Specialty Pharmacy in Rheumatoid ArthritisAdvertisement
Related to this article

A value-based care pilot within Kentucky’s Medicaid program reduced total costs for adults with substance use disorder while improving utilization of evidence-based treatments.

A scalable, symptom-focused patient education model paired with coordinated podiatric care offers managed care organizations a low-barrier strategy to reduce diabetic foot ulcers and costly amputations.

This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.
Advertisement
Advertisement
Trending on AJMC
1
Health Equity & Access Weekly Roundup: November 20, 2026
2
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor
3
Four Ways to Boost Awareness, Access for COVID-19 PEP
4
Defining High-Efficacy MS Therapy: Access, Formularies, and Patient Choice
5

